Myocardial gene transfer: Routes and devices for regulation of transgene expression by modulation of cellular permeability

Human Gene Therapy

Volumn 24, Issue 4, 2013, Pages 375-392

  Katz, Michael G ^a   Fargnoli, Anthony S ^a   Bridges, Charles R ^a  

^a LEVINE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BRADYKININ; CELL PENETRATING PEPTIDE; GLYCERYL TRINITRATE; HISTAMINE; LUCIFERASE; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN; VASCULOTROPIN; VASCULOTROPIN 165; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CAPILLARY PERMEABILITY; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; ELECTRIC FIELD BASED TRANSFECTION; ELECTROPORATION; EXOSOME; EXTRACELLULAR CALCIUM; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE GUN DELIVERY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEART; HEART DISEASE; ISCHEMIC PRECONDITIONING; JET INJECTION DELIVERY; LASER; LASER BASED TRANSFECTION; MAGNETIC FIELD BASED TRANSFECTION; MEMBRANE DAMAGE; MEMBRANE VESICLE; MODULATION; MYOCARDIAL GENE TRANSFER; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OXYGENATION; REVIEW; ULTRASOUND; ULTRASOUND BASED TRANSFECTION; VASCULAR ENDOTHELIUM;

ANIMALS; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HEART DISEASES; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; TRANSGENES;

EID: 84876540956     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.241     Document Type: Review

References (111)

1. Al-Dosari, M.S., and Gao X. (2009). Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 11, 671-681.
2. Alvarez-Erviti, L., Seow, Y., Yin, H., et al. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnol. 29, 341-345.
3. Arora, A., Hakim, I., Baxter, J., et al. (2007). Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc. Natl. Acad. Sci. USA 104, 4255-4260.
4. Ayuni, E.L., Gazdhar, A., Giraud, M.N., et al. (2010). In vivo electroporation mediated gene delivery to the beating heart. PLoS One 5, e14467.
5. Bates, D.O., and Curry, F.E. (1997). Vascular endothelial growth factor increases microvascular permeability via a Ca(2 + ) dependent pathway. Am. J. Physiol. 273, H687-694.
6. Bekeredjian, R., Chen, S., Frenkel, P.A., et al. (2003). Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108, 1022-1026.
7. Bian, J., Popovic, Z.B., Benejam, C, et al. (2007). Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ. Res. 100, 1626-1633.
8. Bish, L.T., Sweeney, H.L., Müller, O.J., et al. (2011). Adeno-associated virus vector delivery to the heart. Methods Mol. Biol. 807, 219-237.
9. Boekstegers, P., von Degenfeld, G, Giehrl, W., et al. (2000). Myocardial gene transfer by selective pressure-regulated retro-infusion of coronary veins. Gene Ther. 7, 232-240.
10. Bridges, CR, Burkman, J.M., Malekan, R, et al. (2002). Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann. Thorac. Surg. 73, 1939-1946.
11. Budker, V., Budker, T., Zhang, G, et al. (2000). Hypothesis: naked DNA is taken up by cells in vivo by a receptor-mediated process. J. Gene Med. 2, 76-88.
12. Champion, HC, Georgakopoulos, D., Haldar, S., et al. (2003). Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart. Circulation 108, 2790-2797.
13. Chang, D.C. Structure and dynamics of electric field-induced membrane pores as revealed by rapid-freezing electron microscopy. In Guide to Electroporation and Electrofusion. Chang, D.C, Chassy, B.M., Saunders, J.A., and Sowers, A.E., eds. (Academic Press, Orlando, FL) pp. 9-27.
14. Coura Rdos, S., and Nardi, N.B. (2008). A role for adeno-associated viral vectors in gene therapy. Gen. Mol. Biol. 31, 1-11.
15. del Monte, F., and Hajjar, RJ. (2003). Efficient viral gene transfer to rodent hearts in vivo. Methods Mol. Biol. 219, 179-193.
16. Ding, W., Zhang, L., Yan, Z., et al. (2005). Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 12, 873-880.
17. Ding, Z., Fach, C, Sasse, A., et al. (2004). A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther. 11, 260-265.
18. Donahue, J.K., Kikkawa, K., Johns, D.C, et al. (1997). Ultrarapid, highly efficient viral gene transfer to the heart. Proc. Natl. Acad. Sci. USA 94, 4664-4668.
19. Donahue, J.K., Kikkawa, K., Thomas, A.D., et al. (1998). Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther. 5, 630-634.
20. Ehringer, W.D., Edwards, M.J., and Miller, FN. (1996). Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J. Cell Physiol. 167, 562-569.
21. Eigeldinger-Berthou, S., Buntschu, P., Flück, M., et al. (2012). Electric pulses augment reporter gene expression in the beating heart. J. Gene Med. 14, 191-203.
22. Emani, S.M., Shah, A.S., Bowman, M.K., et al. (2003). Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol. Ther. 8, 306-313.
23. Endoh, M., Koibuchi, N., Sato, M., et al. (2002). Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther. 5, 501-508.
24. Escoffre, J.M., Teissie, J., and Rols, M.P. (2010). Gene transfer: how can the biological barriers be overcome? J. Membrane Biol. 236, 61-74.
25. Fevrier, B., and Raposo, G. (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell. Biol. 16, 415-421.
26. French, B.A., Mazur, W., Geske, R.S., et al. (1994). Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 90, 2414-2424.
27. Fuchs, S., Baffour, R., Shou, M., et al. (2001). Could plasmid-mediated gene transfer into the myocardium be augmented by left ventricular guided laser myocardial injury? Cather Car-diovasc. Intervent. 54, 533-538.
28. Gehl, J. (2003). Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177, 437-447.
29. Golzio, M., Teissie, J., and Rols, M.P. (2002). Direct visualization at the single-cell level of electrically mediated gene delivery. PNAS 99, 1292-1297.
30. Hargrave, B., Downey, H., Strange Jr, R., et al. (2013). Electroporation-mediated gene transfer directly to the swine heart. Gene Ther. 20, 151-157.
31. Harrison, R.L., Byrne, B.J., and Tung, L. (1998). Electroporation- mediated gene transfer in cardiac tissue. FEBS Lett. 435, 1-5.
32. Hayase, M., del Monte, F., Kawase, Y., et al. (2005). Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am. J. Physiol. Heart Circ. Physiol. 288, H2995-3000.
33. Hinkel, R., Trenkwalder, T., and Kupatt, C. (2011). Gene therapy for ischemic heart disease. Expert Opin. Biol. Ther. 11, 723-737.
34. Horiki, M., Yamato, E., Ikegami, H., et al. (2004). Needleless in vivo gene transfer into muscles by jet injection in combination with electroporation. J. Gene Med. 6, 1134-1138.
35. Hou, D., Maclaughlin, F., Thiesse, M., et al. (2003).Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Cath. Cardi-ovasc. Interv. 58, 207-211.
36. Huang, M., Nguyen, P., Jia, F., et al. (2011). Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 124[suppl 1], S46-S54.
37. Ikeda, Y., Gu, Y., Iwanaga., Y., et al. (2002). Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation 105, 502-508.
38. Jacobson, J.R., Dudek, S.M., Singleton, P.A., et al. (2006). En-dothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L289-295.
39. Kami, D., Takeda, S., Itakura, Y., et al. (2011). Application of magnetic nanoparticles to gene delivery. Int. J. Mol. Sci. 12, 3705-3722.
40. Katz, M.G., Swain, J.D., Tomasulo, C.E., et al. (2011). Current strategies for myocardial gene delivery. J. Mol. Cell Cardiol. 50, 766-776.
41. Katz, M.G., Fargnoli, A.S., Pritchette, L.A., et al. (2012). Gene delivery technologies for cardiac applications. Gene Ther. 19, 659-669.
42. Kay, M.A., Glorioso, J.C., and Naldini, L. (2001). Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature Med. 7, 33-40.
43. Kaye, D.M., Preovolos, A., Marshall, T., et al. (2007). Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J. Am. Coll. Cardiol. 50, 253-260.
44. Klein, T.M., Wolf, E.D., Wu, R., et al. (1987). High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327, 70-73.
45. Ko, Y.T., Hartner, W.C., Kale, A., et al. (2009). Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther. 16, 52-59.
46. Kondo, I., Ohmori, K., Takeuchi, H., et al. (2004). Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44, 644-653.
47. Koren, E., and Torchilin, V.P. (2012). Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med. 18, 385-393.
48. Krötz, F., Sohn, H.Y., Gloe, T., et al. (2003). Magnetofection potentiates gene delivery to cultured endothelial cells. Vas. Res. 40, 425-434.
49. Kumar, A., Jena, P.K., Bahera, S., et al. (2010). Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 6, 64-69.
50. Kumar, P., Shen, Q., Pivetti, C.D., et al. (2009). Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev. Mol. Med. 11, e19.
51. Kurata, S., Tsukakoshi, M., Kasuya, Y., et al. (1986).The laser method for efficient introduction of foreign DNA into cultured cells. Exp. Cell Res. 162, 372-378.
52. Lavigne, M.D., and Gorecki, D.C. (2006). Emerging vectors and targeting methods for nonviral gene therapy. Expert Opin. Emerg. Drugs 11, 541-557.
53. Lechardeur, D., Verkman, A.S., and Lukacs, G.L. (2005). In-tracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Deliv. Rev. 57, 755-767.
54. Li, W., Ma, N., Ong, L.L., et al. (2008). Enhanced thoracic gene delivery by magnetic nanobead-mediated vector. J. Gene Med. 10, 897-909.
55. Lin, H., Parmacek, M.S., Morle, G., et al. (1990). Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82, 2217-2221.
56. Lipskaia, L., Chemaly, E.R., Hadri, L., et al. (2010). Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure. Expert Opin. Biol. Ther. 10, 29-41.
57. Logeart, D., Hatem, S.N., Rü cker-Martin, C., et al. (2000). Highly efficient adenovirus-mediated gene transfer to cardiac myo-cytes after single-pass coronary delivery. Hum. Gene Ther. 11, 1015-1022.
58. Logeart, D., Hatem, S.N., Heimburger, M., et al. (2001). How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures. Hum. Gene Ther. 12, 1601-1610.
59. Lurquin, P.F. (1997). Gene transfer by electroporation. Mol. Biotechnol. 7, 5-35.
60. Lyons, M., Onion, D., Green, N.K., et al. (2006). Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol. Ther. 14, 118-128.
61. Marshall, W.G., Boone, B.A., Burgos, J.D., et al. (2010). Electro-poration mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther. 17, 419-423.
62. Matsuno, Y., Iwata, H., Umeda, Y., et al. (2003). Nonviral gene gun mediated transfer into the beating heart. ASAIO 49, 641-644.
63. Mayrhofer, P., Schleef, M., and Jechlinger, W. (2009). Use of minicircle plasmids for gene therapy. Methods Mol. Biol. 542, 87-104.
64. McMahon, J.M., and Wells, D.J. (2004). Electroporation for gene transfer to skeletal muscles: current status. Biol. Drugs 18, 155-165.
65. Medina-Kauwe, L.K., Xie, J., and Hamm-Alvarez, S. (2005). In-tracellular trafficking of nonviral vectors. Gene Ther. 12, 1734-1751.
66. Mehier-Humbert, S., and Guy, R.H. (2005). Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv. Drug Deliv. Rev. 57, 733-753.
67. Melo, L.G., Gnecchi, M., Pachori, A.S., et al. (2004). Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb. Vasc. Biol. 24, 1761-1774.
68. Michel, C.C., and Kendall, S. (1997). Differing effects of histamine and serotonin on microvascular permeability in anaesthetized rats. J. Physiol. 501, 657-662.
69. Minamino, T., Kitakaze, M., Komamura, K., et al. (2005). Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway. Arterioscler. Thromb. Vasc. Biol. 15, 2298-2304.
70. Mü ller, O.J., Katus, H.A., and Bekeredjian, R. (2007). Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc. Res. 73, 453-462.
71. Nagata, K., Marban, E., Lawrence, J.H., et al. (2001). Phospho-diesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J. Mol. Cell Cardiol. 33, 575-580.
72. Nikolskaya, A.V., Nikolski, V.P., and Efimov, I.R. (2006). Gene printer: laser-scanning targeted transfection of cultured cardiac neonatal rat cells. Cell Commun Adhes. 13, 217-222.
73. Nishizaki, K., Mazda, O., Dohi, Y., et al. (2000). In vivo gene gun-mediated transduction into rat heart with epstein-barr virus-based episomal vectors. Ann. Thorac. Surg. 70, 1332-1337.
74. Nonnenmacher, M., and Weber, T. (2012). Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther. 19, 649-658.
75. Plank, C., Schillinger, U., Scherer, F., et al. (2003). The magne-tofection method: using magnetic force to enhance gene delivery. Biol. Chem. 384, 737-747.
76. Quarck, R., and Holvoet, P. (2004). Gene therapy for cardiovascular diseases. Curr. Gene Ther. 4, 207-223.
77. Raake, P.W., von Degenfeld, G., Hinkel, R., et al. (2004). Myo-cardial gene transfer by selective pressure-regulated retro-infusion of coronary veins. J. Am. Coll. Cardiol. 44, 1124-1129.
78. Raake, P.W., Hinkel, R., Mü ller, S., et al. (2008). Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther. 15, 12-17.
79. Rajaratnam, N., Steffler, P.M., Rizvi, S.A.H., et al. (1994). An experimental study of very high velocity circular water jets in air. J. Hydraul. Res. 32, 461-470.
80. Rapti, K., Chaanine, A.H., and Hajjar, R.J. (2011). Targeted gene therapy for the treatment of heart failure. Can. J. Cardiol. 27, 265-283.
81. Ren, S., Li, M., Smith, J.M., et al. (2002). Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol. 2, 1-6.
82. Rengo, G., Lymperopoulos, A., Zincarelli, C., et al. (2009). Myo-cardial adeno-associated virus serotype 6-bARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 119, 89-98.
83. Roberts, W.G., and Palade, G.E. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Science 108, 2369-2379.
84. Sasano, T., Kikuchi, K., McDonald, A.D., et al. (2007). Targeted high-efficiency, homogeneous myocardial gene transfer. J. Mol. Cell Cardiol. 42, 954-961.
85. Satkauskas, S., Bureau, M.F., Puc, M., et al. (2002). Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol. Ther. 5, 133-140.
86. Sayeed-Shah, U., Mann, M.J., Martin, J., et al. (1998). Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revasculari-zation. J. Thorac. Cardiovasc. Surg. 116, 763-769.
87. Scherer, F., Anton, M., Schillinger, U., et al. (2002). Magnetofec-tion: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102-109.
88. Skepper, J.N., Pierson, R.N., Young, V.K., et al. (1998). Cyto-chemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion. Microsc. Res. Tech. 42, 369-385.
89. Stephens, D.J., and Pepperkok, R. (2001). The many ways to cross the plasma membrane. Proc. Natl. Acad. Sci. USA 98, 4295-4298.
90. Tan, A., Rajadas, J., and Seifalian, A.M. (2012). Exosomes as nano-theranostic delivery platforms for gene therapy. Adv. Drug Deliv. Rev. [Epub ahead of print]; DOI: 10.1016/j.addr.2012.06.014.
91. Tang, T., and Hammond, H.K. (2007). Cell-based GATA4 Cardiac gene transfer using cell-penetrating peptide. Circ. Res. 100, 1540-1542.
92. Tang, T., Gao, M.H., and Hammond H.K. (2012). Prospects for gene transfer for clinical heart failure. Gene Ther. 19, 606-612.
93. Taniyama, Y., Tachibana, K., Hiraoka, K., et al. (2002). Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 6, 372-380.
94. Teissie, J., Golzio, M., and Rols, M.P. (2005). Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of?) knowledge. Biochim. Biophys. Acta 1724, 270-280.
95. Tilemann, L., Ishikawa, K., Weber, T., et al. (2012). Gene therapy for heart failure. Circ. Res. 110, 777-793.
96. Tio, R.A., Tkebuchaya, T., Scheuermann, T.H., et al. (1999). In-tramyocardial gene therapy with naked DNA encoding VEGF improves collateral flow to ischemic myocardium. Hum. Gene Ther. 10, 2953-2960.
97. Tsuji, T., del Monte, F., Yoshikawa, Y., et al. (2009). Rescue of Ca2 + overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am. J. Physiol. Heart Circ. Physiol. 296, H310-H317.
98. Tsukakoshi, M., Kurata, S., Nomiya, Y., et al. (1984). Novel method of DNA transfection by laser microbeam cell surgery. Appl. Phys. B: Photophys. Laser Chem. 35, 135-140.
99. Tsunoda, S., Mazda, O., Oda, Y., et al. (2005). Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem. Biophys. Res. Commun. 336, 118-127.
100. Vera Janavel, G.L., De Lorenzi, A., Cortes, C., et al. (2012). Effect of VEGF gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after 2 months of coronary artery occlusion. J. Gene Med. 14, 279-287.
101. Villemejane, J., and Mir, L.M. (2009). Physical methods of nucleic acid transfer: general concepts and applications. Brit. J. Pharmacol. 157, 207-219.
102. Vogt, A.M., Ando, H., Arras, M., et al. (1998). Lack of adenosine causes myocardial refractoriness. J. Am. Coll. Cardiol. 31, 1134-1141.
103. Wasala, N.B., Shin, J.H., and Duan, D. (2011). The evolution of heart gene delivery vectors. J. Gene Med. 13, 557-565.
104. Wells, D.J. (2004). Gene therapy progress and prospects: elec-troporation and other physical methods. Gene Ther. 11, 1363-1369.
105. White, J.D., Thesier, D.M., Swain, J.D., et al. (2011). Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther. 18, 546-552.
106. Wright, M.J., Wightman, L.M.L., Latchman, D.S., et al. (2001). In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther. 8, 1833-1839.
107. Yang, N.S., and Sun W.H. (1995). Gene gun and other non-viral approaches for cancer gene therapy. Nat. Med. 1, 481-483.
108. Yang, N.S., Burkholder, J., Roberts, B., et al. (1990). In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572.
109. Yao, C.P., Zhang, Z.X., Rahmanzadeh, R., et al. (2008). Laser-based gene transfection and gene therapy. IEEE Trans Nano-biosc. 7, 111-119.
110. Zeira, E., Manevitch, A., Khatchatouriants, A., et al. (2003). Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol. Ther. 8, 342-350.
111. Zhigang, W., Zhiyu, L., Haitao, R., et al. (2004). Ultrasoundmediated microbubble destruction enhances VEGF gene delivery to the infracted myocardium in rats. Clin. Imaging 28, 395-398.